Research

Approximately one in every five adults1 has sleep-disordered breathing (SDB).

An expanding body of scientific evidence clearly indicates that SDB has a profound negative impact on public health.

Through its strong partnership with the global medical community, ResMed is committed to:

  • Increasing awareness of the dangers of untreated SDB
  • Supporting ongoing research into the correlation of SDB with other health risks
  • Finding effective clinical solutions to improve the health and lives of SDB patients

At ResMed, we are focused on developing our industry and patient expertise in sleep and respiratory disorders. That’s why we continue to research areas related to sleep-disordered breathing.

Sleep

ResMed is a global pioneer and leader in sleep and respiratory disorders. All about our research on sleep-disordered breathing and related innovation and technology.

Sleep disordered breathing and mandibular repositioning devices

There’s a growing body of clinical research that demonstrates the efficacy and compliance of mandibular repositioning devices (MRDs) in treating osbstructive sleep apnoea and snoring. The following clinical research papers demonstrate results in particular for ResMed’s Narval CC™ MRD.

Cardiology

ResMed is committed to researching the association between sleep apnoea and cardiovascular issues. All about our research on sleep and cardiology, specifically on heart failure and CSA-CSR.

Respiratory care

At ResMed, we provide a number of solutions to treat respiratory disorders. Noninvasive ventilation (NIV) can used to treat patients with respiratory dysfunction. All about respiratory care and NIV.

iVAPS algorithms

At ResMed, we’re focused on improving patient compliance. That’s why we continue to develop ventilators around iVAPS algorithms, an innovative technology that adapts to patients.

Farrell historical landmarks

ResMed Founder and Chairman Dr. Peter Farrell identifies key research findings that are shaping the field of sleep medicine today.

Sleep apnoea and digital connected health

Recent research findings show the positive effects of connected health on the treatment of sleep apnoea patients.

iVAPS vs. standard NIV

Randomised trial of 'intelligent' autotitrating ventilation versus standard pressure support non-invasive ventilation: Impact on adherence and physiological outcomes.

Benefits of noninvasive ventilation for COPD in the hospital and home

NIV helps patients with COPD and hypercapnia in hospital and at home.

Recurrent acidotic exacerbations of COPD

Patients with chronic obstructive pulmonary disease (COPD) tend to have frequent exacerbations necessitating hospital admission.

Comparison of S/T mode with iVAPS mode for a COPD patient

Case study of an elderly COPD patient who was switched from ST mode to iVAPS

Improving survival in COPD using NPPV

A prospective, randomised, controlled trial of NPPV in severe stable COPD.

Home ventilation lowers risks in COPD

Lowering the risk of acidotic respiratory failure with non-invasive ventilation at home.

Identifying COPD exacerbations early

Monitoring respiratory frequency at home can facilitate early intervention for COPD patients experiencing exacerbations.

NIV Initiation Protocol

How to initiate NIV in patients with chronic respiratory insufficiency or failure.

ResMed is dedicated to innovating and changing lives. We support and actively engage in research initiatives in five associated areas of clinical focus related to sleep-disordered breathing.

Occupational health and safety research at ResMed

ResMed is dedicated to innovating and changing lives. We support and actively engage in research initiatives related to occupational health and safety.

ResMed Support for Investigator-Initiated Research

As part of our commitment to deliver innovative therapies to patients across the globe, ResMed believes in the need to support ethical, independent clinical research, conducted by qualified third-party investigators.

ResMed Academy Online

ResMed Academy Online is designed to provide healthcare and medical equipment professionals with easy access to a variety of learning resources. Learners can enroll in online courses, complete learning activities, and track the progress of their online course completion in the comfort of their home or work.

Diabetes research at ResMed

ResMed is dedicated to innovating and changing lives. We support and actively engage in research initiatives related to type 2 diabetes.

Peri-operative care research at ResMed

ResMed is dedicated to innovating and changing lives. We support and actively engage in research initiatives related to peri-operative care.

Other research at ResMed

ResMed is dedicated to innovating and changing lives. We support and actively engage in research initiatives related to sleep-disordered breathing.

Clinical results for Narval CC™ – the ORCADES study

The 5-year multicentre ORCADES study demonstrated both the efficacy and compliance of the Narval CC™ MRD.

Narval CC delivers strong results

Narval CC packs custom-made comfort into a small, lightweight device, making it easy for patients to be compliant and obtain high efficacy.

Narval CC clinical research

There’s a growing body of clinical research that demonstrates the efficacy and compliance of mandibular repositioning devices (MRDs) in treating obstructive sleep apnoea and snoring. The following clinical research papers demonstrate results in particular for ResMed’s Narval CC™ MRD.

Cardiology research at ResMed

ResMed is dedicated to innovating and changing lives. We support and actively engage in research initiatives related to cardiology.

Clinical Trial Published in JAMA Offers New Hope for COPD Patients

People suffering from chronic obstructive pulmonary disease (COPD) - the third leading cause of death in the United States - may see their lives change thanks to a ResMed-sponsored clinical trial (NYSE: RMD) presented at the 2017 American Thoracic Society International Conference and published in the Journal of the American Medical Association (JAMA) today.

Phase IV SERVE-HF study

Choose your language.

ResMed presents data on Phase IV SERVE-HF study

ResMed presents data on Phase IV SERVE-HF study of Adaptive Servo-Ventilation therapy in central sleep apnea and chronic symptomatic heart failure at ESC Congress 2015.

Chronic Obstructive Pulmonary Disease (overlap syndrome)

Obstructive Sleep Apnoea (OSA) and chronic obstructive pulmonary disease (COPD) often coexist within a patient. Learn more about overlap syndrome on our research initiative page.

ResMed Expands COPD Offering as New Data Reveals Benefits of Home Non-Invasive Ventilation

New research released at European Respiratory Society (ERS) International Congress 2016 highlights the benefits of home non-invasive ventilation (NIV), with the potential to positively impact current practice and improve the lives of patients with COPD

New ResMed-sponsored Study Shows Promising Treatment Option for Patients with Untreated Central Sleep Apnea

Largest-ever analysis of patients with treatment-emergent central sleep apnea shows switching from CPAP to ASV significantly improves compliance.

Clinical Trial Published in JAMA Offers New Hope for COPD Patients

People suffering from chronic obstructive pulmonary disease (COPD) - the third leading cause of death in the United States - may see their lives change thanks to a ResMed-sponsored clinical trial (NYSE: RMD) presented at the 2017 American Thoracic Society International Conference and published in the Journal of the American Medical Association (JAMA) today.